Swiss National Bank
LUNG icon

Swiss National Bank’s Pulmonx LUNG Stock Holding History

Swiss National Bank’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-67,500
Closed -$626K – 2494
2024
Q1 		$626K Hold
67,500
– – ﹤0.01% 2409
2023
Q4 		$861K Sell
67,500
-10,600
-14% -$110K ﹤0.01% 2320
2023
Q3 		$807K Hold
78,100
– – ﹤0.01% 2359
2023
Q2 		$1.02M Buy
78,100
+17,600
+29% +$215K ﹤0.01% 2279
2023
Q1 		$676K Sell
60,500
-5,500
-8% -$54.3K ﹤0.01% 2443
2022
Q4 		$556K Hold
66,000
– – ﹤0.01% 2549
2022
Q3 		$1.1M Buy
66,000
+900
+1% +$16.6K ﹤0.01% 2284
2022
Q2 		$958K Buy
65,100
+17,200
+36% +$354K ﹤0.01% 2394
2022
Q1 		$1.19M Buy
47,900
+3,900
+9% +$101K ﹤0.01% 2322
2021
Q4 		$1.41M Hold
44,000
– – ﹤0.01% 2271
2021
Q3 		$1.58M Buy
44,000
+700
+2% +$27.5K ﹤0.01% 2197
2021
Q2 		$1.91M Buy
+43,300
New +$1.89M ﹤0.01% 2130

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Swiss National Bank's LUNG Position: Q2 2024 in Review

Swiss National Bank sold out of Pulmonx (LUNG) in Q2 2024, closing a stake of 67,500 shares — an estimated $626K sold.

Swiss National Bank first reported a position in LUNG in Q2 2021 and held it in 12 quarters. The position peaked at $1.91M in Q2 2021. 111 funds tracked by Wall St. Rank hold LUNG as of Q2 2024.

  • Swiss National Bank reported no remaining Pulmonx position as of Q2 2024 after selling out during the quarter.
  • Swiss National Bank sold 67,500 Pulmonx shares in Q2 2024, an estimated $626K.
  • Swiss National Bank first reported a position in Pulmonx in Q2 2021 and held it in 12 quarters.
  • Swiss National Bank's Pulmonx position peaked at $1.91M in Q2 2021.
  • 111 funds tracked by Wall St. Rank held Pulmonx as of Q2 2024.

Based on Swiss National Bank's 13F filing for Q2 2024, filed 8 Aug 2024.